Australia markets closed

Arcturus Therapeutics Holdings Inc. (ARCT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
30.50+0.72 (+2.42%)
At close: 04:00PM EDT
29.78 -0.72 (-2.36%)
After hours: 04:32PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
110,617
157,748
205,755
12,359
9,539
Operating expenses
Research development
193,938
192,133
147,751
173,760
57,846
Selling general and administrative
53,960
52,871
46,071
41,451
23,217
Total operating expenses
233,989
235,953
193,578
215,211
81,063
Operating income or loss
-123,372
-78,205
12,177
-202,852
-71,524
Interest expense
24
767
3,001
2,674
831
Total other income/expenses net
46
33,724
-1,113
1,099
-263
Income before tax
-105,196
-27,890
10,644
-203,674
-72,148
Income tax expense
2,100
1,835
1,295
0
-
Income from continuing operations
-107,296
-29,725
9,349
-203,674
-72,148
Net income
-107,296
-29,725
9,349
-203,674
-72,148
Net income available to common shareholders
-107,296
-29,725
9,349
-203,674
-72,148
Basic EPS
3.76
-1.12
0.35
-7.74
-3.55
Diluted EPS
3.76
-1.12
0.35
-7.74
-3.55
Basic average shares
26,547
26,628
26,445
26,317
20,305
Diluted average shares
27,195
26,628
27,093
26,317
20,305